Genovations™
Genes do not always equal fate
Many people mistakenly assume that the presence of certain gene - or a genetic flaw - means they are destined to experience the associated diseases. This is not true! Most genes have flexible expressions and often are influenced by modifiable environmental, diet and lifestyle factors.
Only a very few rare diseases, such as Huntington's or Tay Sachs, are certainties determined by genetic makeup. Experts believe that nearly all of the most pervasive, disabling and deadly degenerative diseases, including heart disease, adult-onset diabetes, cancer and senile dementia, develop from an ongoing interaction between genetic and environmental factors.
Poor diet; chronic nutritional deficiencies; hormone imbalances; unhealthy lifestyle habits; bacterial infection; toxic exposure to cigarette smoke, air pollution or other substances; excessive alcohol consumption; sun exposure or bacterial infection can play a role in whether or not disease develops. Over time, these harmful agents and conditions can switch on a gene's ability to promote disease.
Minimise Risk
By evaluating a carefully selected group of genetic variants, each Genovations™ profile provides a glimpse into your potential health future. The advantage: you will be empowered to modify the expression of disease years before a condition might otherwise develop. Genetic testing enables you to minimise risk by:
- Identifying hidden gene mutations that may promote chronic disease
- Preventing disease through early intervention
- Modifying gene expression through more precise, targeted, individualised interventions
- Identifying key areas for follow-up
- Monitoring therapeutic effectiveness of intervention strategies with laboratory testing
Whether or not you choose to 'see' your genes, they are always there and will continue to play an important role in your health. By choosing to look at them, you have the opportunity to influence the ultimate outcome and more actively promote a healthy life. The Genovations™ brand of predictive genomic testing offers the following profiles:
Cardiogenomicplus Profile
Identifies genomic risk in areas such as blood pressure regulation, lipid balance, nutrient metabolism, inflammation and oxidative stress.
Osteogenomic Profile
Identifies genomic risk for rapid bone loss and hormone dysfunction.
Estrogenomic Profile
Identifies genomic risk in genes that modulate oestrogen metabolism, coagulation, cardiovascular disease and osteoporosis.
Immunogenomic Profile
Identifies genomic risk for arthritis, asthma and allergies.
Detoxigenomic Profile
Identifies genomic risk for chemical sensitivities, oxidative stress, and ability to handle various medications.
Neurogenomic Profile
Identifies genomic indicators of weak detoxification capacity and possible adverse drug reactions. This test can help determine if susceptibility to heavy metals or high oxidative stress might be contributing to learning or behavioural disorders.
